Cancer drug development time halved thanks to artificial intelligence

The drug can help cells metabolise glucose again, letting them die off  A cancer-fighting drug is on target to be brought to market in half the expected time thanks to the use of artificial inteligence in testing, a start up has claimed. Berg Health, a pharmaceutical startup founded in 2008 with Silicon Valley venture capital backing, said it expected the drug to go on sale within three years, marking seven years in development compared to the general 14. Healthy cells feed on glucose in the body and die off, in a process known as cell death, when their usefulness draws to a close. But in some circumstances the mitochondria – the parts of the cell that provide its energy – malfunction and metabolise lactic acid instead of glucose, turning off…


Link to Full Article: Cancer drug development time halved thanks to artificial intelligence